California State Teachers Retirement System (CalSTRS)’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
138,259
+39,253
+40% +$500K ﹤0.01% 1584
2025
Q4
$890K Buy
99,006
+9,376
+10% +$129K ﹤0.01% 1846
2025
Q3
$1.55M Buy
89,630
+5
+0% +$62 ﹤0.01% 1557
2025
Q2
$841K Sell
89,625
-1,013
-1% -$8.32K ﹤0.01% 1834
2025
Q1
$644K Hold
90,638
﹤0.01% 1934
2024
Q4
$1.06M Buy
90,638
+3,596
+4% +$56.1K ﹤0.01% 1734
2024
Q3
$1.79M Sell
87,042
-2,809
-3% -$64.8K ﹤0.01% 1461
2024
Q2
$2.01M Buy
89,851
+4,320
+5% +$103K ﹤0.01% 1370
2024
Q1
$2.35M Sell
85,531
-3,869
-4% -$107K ﹤0.01% 1314
2023
Q4
$2.73M Sell
89,400
-213
-0.2% -$6.12K ﹤0.01% 1264
2023
Q3
$2.83M Sell
89,613
-9,441
-10% -$366K ﹤0.01% 1191
2023
Q2
$4.04M Buy
99,054
+6,000
+6% +$243K 0.01% 1076
2023
Q1
$3.47M Sell
93,054
-401
-0.4% -$15.7K 0.01% 1140
2022
Q4
$3.26M Buy
93,455
+4,933
+6% +$235K 0.01% 1193
2022
Q3
$4.95M Sell
88,522
-838
-0.9% -$52K 0.01% 909
2022
Q2
$4.63M Buy
89,360
+2,387
+3% +$121K 0.01% 994
2022
Q1
$6.32M Sell
86,973
-6,968
-7% -$590K 0.01% 928
2021
Q4
$11.1M Buy
93,941
+6,505
+7% +$815K 0.01% 727
2021
Q3
$11.7M Sell
87,436
-608
-0.7% -$92.1K 0.02% 745
2021
Q2
$14.3M Buy
88,044
+5,298
+6% +$413K 0.02% 688
2021
Q1
$6.64M Buy
82,746
+6,912
+9% +$464K 0.01% 1010
2020
Q4
$4.13M Hold
75,834
0.01% 1227
2020
Q3
$1.51M Buy
75,834
+9,749
+15% +$203K ﹤0.01% 1657
2020
Q2
$1.39M Buy
66,085
+7,693
+13% +$131K ﹤0.01% 1680
2020
Q1
$714K Sell
58,392
-1,852
-3% -$24.9K ﹤0.01% 1867
2019
Q4
$884K Hold
60,244
﹤0.01% 2040
2019
Q3
$804K Buy
60,244
+4,193
+7% +$66.9K ﹤0.01% 2063
2019
Q2
$918K Buy
56,051
+5,180
+10% +$81.4K ﹤0.01% 2017
2019
Q1
$869K Sell
50,871
-1,167
-2% -$17.4K ﹤0.01% 2011
2018
Q4
$710K Buy
52,038
+1,209
+2% +$22.5K ﹤0.01% 2093
2018
Q3
$1.46M Sell
50,829
-18
-0% -$524 ﹤0.01% 1824
2018
Q2
$1.39M Buy
50,847
+25,577
+101% +$620K ﹤0.01% 1841
2018
Q1
$533K Sell
25,270
-1,002
-4% -$24.6K ﹤0.01% 2324
2017
Q4
$505K Buy
26,272
+2,929
+13% +$67.6K ﹤0.01% 2403
2017
Q3
$580K Sell
23,343
-1,800
-7% -$33.9K ﹤0.01% 2343
2017
Q2
$402K Buy
25,143
+11,100
+79% +$155K ﹤0.01% 2592
2017
Q1
$198K Sell
14,043
-300
-2% -$4.03K ﹤0.01% 2823
2016
Q4
$188K Sell
14,343
-400
-3% -$6.01K ﹤0.01% 2872
2016
Q3
$251K Buy
14,743
+100
+0.7% +$1.94K ﹤0.01% 2823
2016
Q2
$313K Buy
+14,643
New +$390K ﹤0.01% 2733

Other funds holding NTLA

California State Teachers Retirement System (CalSTRS)'s NTLA Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Intellia Therapeutics (NTLA) stake by 40% in Q1 2026, buying an estimated $500K and bringing the position to 138,259 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

California State Teachers Retirement System (CalSTRS) first reported a position in NTLA in Q2 2016 and has held it in 40 quarters since. The position peaked at $14.3M in Q2 2021. 303 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 138,259 shares of Intellia Therapeutics worth $1.77M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 39,253 Intellia Therapeutics shares in Q1 2026, an estimated $500K.
  • Intellia Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1584 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Intellia Therapeutics in Q2 2016 and has held it in 40 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Intellia Therapeutics position peaked at $14.3M in Q2 2021.
  • 303 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.